TriSalus Life Sciences, Inc. Cash
TriSalus Life Sciences, Inc. (TLSI) had Cash of $103.97 thousand as of 2023-06-30, per its 10-Q filed 2023-08-02.
Discontinued › Balance Sheet › Assets › Assets, Current › Cash and Cash Equivalent
us-gaap:Cash · last filed 2023-08-02
- 2023-06-30: Cash $103.97K.
- 2023-03-31: Cash $136.80K.
- 2022-12-31: Cash $153.56K.
- 2022-09-30: Cash $207.60K.
| Period end | Cash | Cash as first filed |
|---|---|---|
| 2023-06-30 | $103.97K 10-Q · filed 2023-08-02 | |
| 2023-03-31 | $136.80K 10-Q · filed 2023-05-12 | |
| 2022-12-31 | $153.56K 10-Q · filed 2023-08-02 | |
| 2022-09-30 | $207.60K 10-Q · filed 2022-11-10 | |
| 2021-12-31 | $200.88K 10-K · filed 2023-03-22 | |
| 2021-03-31 | $250.04M 10-Q · filed 2021-06-28 | |
| 2020-12-31 | $1.34M 10-K/A · filed 2021-12-13 | $923.00 10-Q · filed 2021-06-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |